Total Valuation
Rua Bioscience Ltd. has a market cap or net worth of $13.58M. The enterprise value is $10.72.
Market Cap$13.58M
Enterprise Value$10.72
Share Statistics
Rua Bioscience Ltd. has 452,588,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding452,588,930
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rua Bioscience Ltd.’s return on equity (ROE) is -0.79 and return on invested capital (ROIC) is -56.03%.
Return on Equity (ROE)-0.79
Return on Assets (ROA)-0.47
Return on Invested Capital (ROIC)-56.03%
Return on Capital Employed (ROCE)-0.79
Revenue Per Employee172.10K
Profits Per Employee-223.98K
Employee Count15
Asset Turnover0.36
Inventory Turnover9.36
Valuation Ratios
The current PE Ratio of Rua Bioscience Ltd. is ―. Rua Bioscience Ltd.’s PEG ratio is 0.06.
PE Ratio―
PS Ratio3.64
PB Ratio2.21
Price to Fair Value2.21
Price to FCF-3.11
Price to Operating Cash Flow-3.89
PEG Ratio0.06
Income Statement
In the last 12 months, Rua Bioscience Ltd. had revenue of 2.58M and earned -3.36M in profits. Earnings per share was -0.01.
Revenue2.58M
Gross Profit-2.93M
Operating Income-3.37M
Pretax Income-3.36M
Net Income-3.36M
EBITDA-2.96M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -3.02M and capital expenditures 3.02M, giving a free cash flow of 0.00 billion.
Operating Cash Flow-3.02M
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Rua Bioscience Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.17
52-Week Price Change-9.09%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)38.42
Average Volume (3m)53.32K
Important Dates
Rua Bioscience Ltd. upcoming earnings date is Mar 4, 2027, After Close (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateMar 4, 2027
Ex-Dividend Date―
Financial Position
Rua Bioscience Ltd. as a current ratio of 1.08, with Debt / Equity ratio of 41.26%
Current Ratio1.08
Quick Ratio0.88
Debt to Market Cap0.18
Net Debt to EBITDA-0.41
Interest Coverage Ratio-10.62
Taxes
In the past 12 months, Rua Bioscience Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Rua Bioscience Ltd. EV to EBITDA ratio is -3.59, with an EV/FCF ratio of -3.51.
EV to Sales4.12
EV to EBITDA-3.59
EV to Free Cash Flow-3.51
EV to Operating Cash Flow-3.52
Balance Sheet
Rua Bioscience Ltd. has $533.70K in cash and marketable securities with $1.76M in debt, giving a net cash position of -$1.22M billion.
Cash & Marketable Securities$533.70K
Total Debt$1.76M
Net Cash-$1.22M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is -97.58%, with operating margin of -130.44%, and net profit margin of -130.14%.
Gross Margin-97.58%
Operating Margin-130.44%
Pretax Margin-130.14%
Net Profit Margin-130.14%
EBITDA Margin-114.61%
EBIT Margin-130.44%
Analyst Forecast
The average price target for Rua Bioscience Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast70.82%
EPS Growth Forecast41.04%